A Study of the Pharmacokinetics of Melphalan During Treatment With Melflufen and Dexamethasone in Patients With Relapsed Refractory Multiple Myeloma and Impaired Renal Function
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2018
At a glance
- Drugs Dexamethasone (Primary) ; Melphalan flufenamide (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions; Pharmacokinetics
- Acronyms BRIDGE
- Sponsors Oncopeptides
- 18 Sep 2018 According to a Oncopeptides media release, the results are expected in late 2019.
- 18 Sep 2018 According to a Oncopeptides media release, first patient has been started with treatment in this trial.
- 27 Aug 2018 New trial record